Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: López Zúñiga M, Martín Toro M, de Damas Medina M. Datos de vida real en el uso de IPCSK9. Rev Clin Esp 2019;219:466-468. [DOI: 10.1016/j.rce.2019.06.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Revised: 02/05/2019] [Accepted: 06/05/2019] [Indexed: 12/19/2022]

For:	López Zúñiga M, Martín Toro M, de Damas Medina M. Datos de vida real en el uso de IPCSK9. Rev Clin Esp 2019;219:466-468. [DOI: 10.1016/j.rce.2019.06.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Revised: 02/05/2019] [Accepted: 06/05/2019] [Indexed: 12/19/2022]

Number

Cited by Other Article(s)

Escudero Quesada V, Pantoja Pérez J, Castro Alonso C, Osma Capera JV, Valero Antón A, Sancho Calabuig A. Experience with PCSK9 inhibitors from a Nephrology unit. Nefrologia 2024;44:111-113. [PMID: 38423835 DOI: 10.1016/j.nefroe.2024.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2024] Open

Experiencia con inhibidores PCSK9 desde una consulta de Nefrología. Nefrologia 2022. [DOI: 10.1016/j.nefro.2022.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open

Guijarro C, Camafort M. PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines? Rev Clin Esp 2020. [DOI: 10.1016/j.rceng.2019.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Guijarro C, Camafort M. Inhibidores de PCSK9: ratificación del papel del colesterol LDL en prevención cardiovascular. ¿Hacia la convergencia en las guías de prevención europeas y norteamericanas? Rev Clin Esp 2020;220:374-382. [DOI: 10.1016/j.rce.2019.05.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Revised: 05/25/2019] [Accepted: 05/27/2019] [Indexed: 10/26/2022]